Athena Diagnostics Sues Ambry Genetics over Diabetes Dx Tests

Athena alleges that Ambry's sale of tests for certain types of diabetes infringes on patents that Athena licensed from its development partner Correlagen.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.